98%
921
2 minutes
20
Virus-like particles (VLPs) are used as nanocontainers for targeted drug, protein, and vaccine delivery. The phage P22 VLP is an ideal macromolecule delivery vehicle, as it has a large exterior surface area, which facilitates multivalent genetic and chemical modifications for cell recognition and penetration. Arginine-rich cell-penetrating peptides (CPPs) can increase cargo transport efficiency . However, studies on the tissue distribution and retention of P22 VLPs mediated by TAT and 8R are lacking. This study aimed to analyze the TAT and 8R effects on the P22 VLPs transport efficiency and tissue distribution both and . We used a prokaryotic system to prepare P22 VLP self-assembled particles and expressed TAT-or 8R-conjugated mCherry on the VLP capsid protein as model cargoes and revealed that the level of P22 VLP-mCherry penetrating the cell membrane was low. However, both TAT and 8R significantly promoted the cellular uptake efficiency of P22 VLPs , as well as enhanced the tissue accumulation and retention of P22 VLPs . At 24 h postinjection, TAT enhanced the tissue distribution and retention in the lung, whereas 8R could be better accumulation in brain. Thus, TAT was superior in terms of cellular uptake and tissue accumulation in the P22 VLPs delivery system. Understanding CPP biocompatibility and tissue retention will expand their potential applications in macromolecular cargo delivery.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11405305 | PMC |
http://dx.doi.org/10.3389/fvets.2024.1460973 | DOI Listing |
Microb Biotechnol
June 2025
Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane, Queensland, Australia.
New therapeutics are urgently needed to curb the spread of drug-resistant diseases. Bioactive peptides (BAPs), including antimicrobial peptides, are emerging as an exciting new class of compounds with advantages over current drug modalities, especially small molecule drugs that are prone to resistance development. Here, we evaluated a bacteriophage P22 virus-like particle (VLP) system where BAPs are encapsulated as fusion proteins with the P22 scaffold protein (SP) within self-assembling protein cages in Escherichia coli.
View Article and Find Full Text PDFSoft Matter
May 2025
Intelligent Systems Engineering, Indiana University, Bloomington, Indiana 47408, USA.
An experimentally-informed coarse-grained model is presented to probe the self-assembly of multiple types of charged nanoparticles in a one-pot mixture in the presence of oppositely charged linkers across a broad range of nanoparticle charge and ionic strength of the solution. The model is applied to study the self-assembly of negatively-charged bacteriophage P22 virus-like particles (VLPs) of different types, with each type comprising VLPs of a distinct surface charge, in the presence of positively-charged polyamidoamine (PAMAM) generation-6 (G6) dendrimers. The model accurately captures the self-assembly of one-component systems, including the assembly states of the highest-charged P22 variant that were inaccessible with earlier models, revealing that P22 VLPs assemble into ordered arrays below a threshold ionic strength that increases with increasing variant charge, consistent with experiments.
View Article and Find Full Text PDFFront Vet Sci
September 2024
State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin, China.
Infect Immun
March 2024
Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, Texas, USA.
Virus-like particles (VLPs) are protein-based nanoparticles frequently used as carriers in conjugate vaccine platforms. VLPs have been used to display foreign antigens for vaccination and to deliver immunotherapy against diseases. Hemolysin-coregulated proteins 1 (Hcp1) is a protein component of the type 6 secretion system, which participates in intracellular invasion and dissemination.
View Article and Find Full Text PDFNanoscale Adv
November 2023
State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing, East China University of Science and Technology Shanghai 200237 China
In the past decade, virus-like particles (VLPs) that can encapsulate single or multiple enzymes have been studied extensively as typical nanoreactors for biocatalysis , yet their catalytic efficiencies are usually inadequate for real applications. These biocatalytic nanoreactors should be engineered like their free-enzyme counterparts to improve their catalytic performance for potential applications. Herein we engineer biocatalytic VLPs for the enhanced synthesis of chiral alcohols.
View Article and Find Full Text PDF